Allegra Orthopaedics specialises in bringing innovation to market. Allegra’s principal product, the Active Total Knee, is such an example and has significantly improved the quality of life for many people globally.
The company is the global licensee to a composite biocompatible ceramic material, known as Sr-HT-Gahnite, from The University of Sydney. The Sr-HT-Gahnite is currently under development and preliminary studies indicate good bioactivity and in-growth of bone into the synthetic scaffold prepared from the ceramic material.
The company continues to build upon its extensive portfolio of patents. Allegra has built strong relationships with medical device companies and research organisations, such as The University of Sydney, University of Wollongong and Queensland University of Technology, as well as Surgeon inventors/innovators. These collaborations have resulted in commercialisation of new medical devices in the market.
To find out more, contact us here.